Novozymes' results for the first half of 2007 are fully in line with the outlook. Sales rose by 14%, while operating profit rose by 20% including one-off items and by 9% based on ordinary activities. Novozymes is maintaining its expectations for sales and operating profit for 2007, while the expectations for net profit are being adjusted upwards. Download the full stock exchange announcement
Attachments
